Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 5.49
(0.37%)
CNY 5.49
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 240.53 Million | 116.09 Million | 102.36 Million | 533.86 Million | 612.39 Million | 791.44 Million |
| Net Income | -421.58 Million | 86.07 Million | 93.86 Million | 319.69 Million | 770.78 Million | 605 Million |
| Depreciation & Amortization | 364.59 Million | 336.51 Million | 294.22 Million | 256.57 Million | 203.1 Million | 192.37 Million |
| Deferred income taxes | -47.47 Million | -1.6 Million | -3.06 Million | 48.72 Million | 27.49 Million | 3.52 Million |
| Stock-based compensation | - | 62.61 Million | 200.35 Million | 37.56 Million | 7.04 Million | 44.13 Million |
| Change in working capital | -67.52 Million | -377.46 Million | -350.16 Million | -142.04 Million | -387.78 Million | -14.8 Million |
| Other non-cash items | 36.12 Million | 9.94 Million | -132.86 Million | 13.35 Million | -8.24 Million | 8.87 Million |
| Investing Cash Flow | -128.21 Million | -620.31 Million | -509 Million | -70.58 Million | 736.59 Million | -1.09 Billion |
| Investments in PPE | -153.07 Million | -179.42 Million | -229.56 Million | -74.18 Million | -160.63 Million | -255.78 Million |
| Acquisitions | 24.34 Million | 5.91 Million | 162.96 Thousand | 3.72 Million | 5.01 Million | 4.41 Million |
| Investment purchases | -42 Million | -464.13 Million | -251.5 Million | -118.9 Thousand | -20 Million | -1.4 Billion |
| Sales/Maturities of investments | 70.55 Million | 5 Million | 2.5 Million | -3.72 Million | 1.16 Billion | 550 Million |
| Other Investing Activities | -28.02 Million | 12.32 Million | -30.61 Million | 3.72 Million | -247.78 Million | -841.64 Million |
| Financing Cash Flow | 99.07 Million | -121.88 Million | 80.78 Million | -11.18 Million | -902.33 Million | -906.27 Million |
| Debt repayment | -57.43 Million | -1.81 Billion | -929 Million | -230 Million | -683.7 Million | -1.5 Billion |
| Dividends payments | -118.93 Million | -161.87 Million | -32.37 Million | -466.71 Million | -466.67 Million | -204.56 Million |
| Common Stock Repurchased | - | - | - | -236.9 Million | -20.27 Million | -295.07 Million |
| Common Stock Issuance | - | - | - | 236.9 Million | 20.27 Million | - |
| Other Financing Activities | 160.56 Million | 1.89 Billion | 1.06 Billion | 696.9 Million | 264.72 Million | 798.29 Million |
| Accounts receivables | 2.74 Million | -229.76 Million | -754.97 Million | -353.17 Million | -276.6 Million | -71.44 Million |
| Accounts payables | -316.52 Million | 67.64 Million | 601.96 Million | 60.28 Million | -191.32 Million | 152.42 Million |
| Inventory | 293.73 Million | -213.73 Million | -194.08 Million | 102.12 Million | 52.64 Million | -99.3 Million |
| Other working capital | -363.99 Million | -1.6 Million | -3.06 Million | 48.72 Million | 27.49 Million | 84.5 Million |
| Cash at beginning of period | 1.03 Billion | 1.58 Billion | 1.93 Billion | 1.52 Billion | 1.06 Billion | 2.24 Billion |
| Cash at end of period | 1.24 Billion | 1.03 Billion | 1.58 Billion | 1.93 Billion | 1.52 Billion | 1.06 Billion |
| Capital Expenditure | -153.07 Million | -179.42 Million | -229.56 Million | -74.18 Million | -160.63 Million | -255.78 Million |
| Effect of forex changes on cash | 1.1 Million | 75.13 Million | -25.53 Million | -38.47 Million | 9.91 Million | 35.68 Million |
| Net cash flow / Change in cash | 212.49 Million | -550.97 Million | -351.39 Million | 413.62 Million | 456.56 Million | -1.17 Billion |
| Free Cash Flow | 87.45 Million | -63.33 Million | -127.19 Million | 459.68 Million | 451.75 Million | 535.66 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -26.12 Million | 5.5 Million | 32.59 Million | -421.58 Million | -381.46 Million | -57.75 Million |
| Depreciation & Amortization | - | 87.6 Million | 87.6 Million | 364.59 Million | 88.9 Million | -188.29 Million |
| Deferred income taxes | - | - | - | -47.47 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -221.01 Million | - | -67.52 Million | 296.47 Million | 56.5 Million |
| Other non-cash items | 19 Million | 200.21 Million | -4.1 Million | 36.12 Million | 439.37 Million | 327.39 Million |
| Investing Cash Flow | 25.18 Million | -71.73 Million | -58.74 Million | -128.21 Million | 5.13 Million | -125.11 Million |
| Investments in PPE | -47.59 Million | -13.93 Million | -23.63 Million | -153.07 Million | -707 Thousand | -54.55 Million |
| Acquisitions | 24.12 Million | - | - | 24.34 Million | 4.02 Million | 2.43 Million |
| Investment purchases | - | - | - | -42 Million | -11.5 Million | -20.5 Million |
| Sales/Maturities of investments | - | - | - | 70.55 Million | -44.85 Million | 1.5 Million |
| Other Investing Activities | 72.78 Million | -57.8 Million | -35.11 Million | -28.02 Million | 13.31 Million | -53.98 Million |
| Financing Cash Flow | -108.14 Million | -217.45 Million | 236.98 Million | 99.07 Million | -363.52 Million | 14.67 Million |
| Debt repayment | -120.4 Million | -128.39 Million | -314.9 Million | -57.43 Million | -466.95 Million | -717.69 Million |
| Dividends payments | -5.51 Million | -7.44 Million | -10.24 Million | -118.93 Million | -6.75 Million | -14.87 Million |
| Common Stock Repurchased | 151.41 Million | -151.41 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 17.77 Million | -81.62 Million | -67.66 Million | 160.56 Million | 110.17 Million | 747.24 Million |
| Accounts receivables | - | -122.18 Million | - | 2.74 Million | 2.74 Million | 93.41 Million |
| Accounts payables | - | - | - | -316.52 Million | - | - |
| Inventory | - | -98.83 Million | - | 293.73 Million | 293.73 Million | -36.9 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.29 Billion | 1.45 Billion | 1.24 Billion | 1.03 Billion | 1.64 Billion | 1.6 Billion |
| Cash at end of period | 1.2 Billion | 1.29 Billion | 1.45 Billion | 1.24 Billion | 1.24 Billion | 1.64 Billion |
| Capital Expenditure | -47.59 Million | -13.93 Million | -23.63 Million | -153.07 Million | -707 Thousand | -54.55 Million |
| Effect of forex changes on cash | 3.17 Million | 7.07 Million | 3.36 Million | 1.1 Million | -26.6 Million | 4.08 Million |
| Net cash flow / Change in cash | -86.9 Million | -163.7 Million | 210.09 Million | 212.49 Million | -391.79 Million | 31.5 Million |
| Free Cash Flow | -54.71 Million | 104.18 Million | 4.85 Million | 87.45 Million | -31.7 Million | 83.29 Million |
GLE
THRL
GRPLTD
THYROCARE
SAKHTISUG
INS